Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection

Hepatocellular carcinoma (HCC) is the third most lethal cancer worldwide; however, accurate prognostic tools are still lacking. We aimed to identify immunohistochemistry (IHC)-based signature as a prognostic classifier to predict recurrence and survival in patients with HCC at Barcelona Clinic Liver...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Bai, Yannan, Lian, Yuane, Chen, Xiaoping, Wu, Jiayi, Lai, Jianlin, Qiu, Funan, Zhou, Songqiang, Zhu, Zijing, Tian, Yifeng, Wang, Yaodong, Yang, Yinghong, Yan, Maolin
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7874098/
https://ncbi.nlm.nih.gov/pubmed/33585243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.616263
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars